PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch

被引:3
|
作者
Nakajima, Koji [1 ]
Kubota, Hirohito [1 ]
Kato, Itaru [1 ]
Isobe, Kiyotaka [1 ]
Ueno, Hiroo [1 ]
Kozuki, Kagehiro [1 ]
Tanaka, Kuniaki [1 ]
Kawabata, Naoko [1 ]
Mikami, Takashi [1 ]
Tamefusa, Kosuke [2 ]
Nishiuchi, Ritsuo [2 ]
Saida, Satoshi [1 ]
Umeda, Katsutsugu [1 ]
Hiramatsu, Hidefumi [1 ]
Adachi, Souichi [3 ]
Takita, Junko [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
[2] Kochi Hlth Sci Ctr, Dept Pediat, Kochi, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan
关键词
infant leukemia; KMT2A rearrangement; lineage switch; PAX5; whole exome sequencing; CELL;
D O I
10.1111/cas.15380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A-rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A-MLLT3-rearranged acute monocytic leukemia, but 6 months thereafter, relapsed as KMT2A-MLLT3-rearranged acute lymphocytic leukemia. Whole exome sequencing of the bone marrow obtained pre-post lineage switch revealed two somatic mutations of PAX5 in the relapse sample. These two PAX5 alterations were suggested to be loss of function, thus to have played the driver role in the lineage switch from acute monocytic leukemia to acute lymphocytic leukemia.
引用
收藏
页码:2472 / 2476
页数:5
相关论文
共 50 条
  • [1] Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series
    Yost, Christine M.
    Gaikwad, Amos S.
    Parsons, D. Williams
    Rabin, Karen R.
    Gant, Vincent U.
    Fisher, Kevin E.
    Marcogliese, Andrea N.
    Schafer, Eric S.
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3515 - 3518
  • [2] Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineage-directed therapies
    Bataller, Alex
    Abuasab, Tareq
    McCall, David
    Wang, Wei
    Cuglievan, Branko
    Issa, Ghayas C.
    Jabbour, Elias
    Short, Nicholas
    DiNardo, Courtney D.
    Tang, Guilin
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Sasaki, Koji
    HAEMATOLOGICA, 2024, 109 (01) : 293 - 297
  • [3] Allelic imbalance in KMT2A-rearranged infant acute lymphoblastic leukemia
    Yoo, Byunggil
    Farooqi, Midhat S.
    Kostadinov, Rumen
    Cheung, Warren
    Farrow, Emily
    Kelley, Shannon
    Miller, Neil
    Ge, Bing
    Gibson, Margaret
    Brown, Patrick
    Guest, Erin M.
    Pastinen, Tomi
    CANCER RESEARCH, 2019, 79 (13)
  • [4] A Case of MLL-AF9 Infant Acute Monocytic Leukemia Characterized by Biallelic PAX5 Alterations at Relapse with Lineage Switch
    Nakajima, Koji
    Kato, Itaru
    Kubota, Hirohito
    Kawabata, Naoko
    Tanaka, Kuniaki
    Kouzuki, Kagehiro
    Saida, Satoshi
    Umeda, Katsutsugu
    Hiramatsu, Hidefumi
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [5] Preclinical Evaluation of Carfilzomib for Infant KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    de Kraa, Rebecca
    Oommen, Joyce
    Chua, Grace-Alyssa
    Singh, Sajla
    Hughes, Anastasia M.
    Ferrari, Emanuela
    Ford, Jette
    Chiu, Sung K.
    Stam, Ronald W.
    Kees, Ursula R.
    Malinge, Sebastien
    Kotecha, Rishi S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Lineage switch from B lymphoblastic leukemia with KMT2A-rearranged to mixed-phenotype acute leukemia under daratumumab
    Marco-Ayala, Javier
    Isabel Vicente, Ana
    Such, Esperanza
    Luna, Irene
    Andreu, Rafael
    Sempere, Amparo
    Romero, Samuel
    Senent Peris, Maria Leonor
    BLOOD RESEARCH, 2020, 55 (02) : 75 - 75
  • [7] Nuclear Structure of KMT2A-Rearranged Infant ALL
    Namikawa, Yui
    Muhaimin, Riski
    Tomomasa, Dan
    Nishimura, Akira
    Ishii, Eiichi
    Tomizawa, Daisuke
    Miyamura, Takako
    Isoda, Takeshi
    Takagi, Masatoshi
    CANCER SCIENCE, 2025, 116 : 563 - 563
  • [8] Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia
    Chiu, Sung K.
    Ferrari, Emanuela
    Oommen, Joyce
    Malinge, Sebastien
    Cheung, Laurence C.
    Kotecha, Rishi S.
    CANCERS, 2025, 17 (03)
  • [9] ACUTE ENCEPHALOPATHY FOLLOWING TUMOR LYSIS SYNDROME IN AN INFANT WITH KMT2A-REARRANGED LEUKEMIA
    Murasawa, Reina
    Ashiarai, Miho
    Yoshihara, Hiroki
    Umehara, Naoki
    Nakatani, Ryo
    Ono, Rintaro
    Hosoya, Yosuke
    Yokoyama, Mina
    Nozaki, Taiki
    Hasegawa, Daisuke
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [10] CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch
    Lee, Benjamin J.
    Griffin, Shawn P.
    Doh, Jean
    Chan, Alexandre
    O'Brien, Susan
    Jeyakumar, Deepa
    Ciurea, Stefan O.
    Becker, Pamela S.
    Kongtim, Piyanuch
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E439 - E443